Elligo Health Research announced the acquisition of Root Health, an AI virtual assistant for clinical research. The acquisition of Root Health adds to Elligo’s commitment of building a technology-forward, integrated healthcare-enabling research organization with a full range of capabilities to improve the efficiency of clinical research and is designed to support easy access for faster enrollment and accelerated trials overall.
“Root Health’s AI virtual assistant fits seamlessly with Elligo’s proprietary IntElligo Research Stack,” said Root Health CEO Raj Sharma. “Root Health was built to improve the patient’s experience in clinical trials while accelerating patient recruitment. Together, we will build stronger healthcare communities and bring clinical research as care to more patients.”
In addition, Elligo announced the addition of COO Miranda Mann Porter, Ph.D., to its leadership team. Porter is an experienced global leader with a diverse background in therapeutics (CNS), operational execution of clinical development programs and Phase I-IV trials, post-marketing medical affairs services, and healthcare delivery.
“Our acquisition of Root Health is yet another example of our tireless efforts to better support our patients and the physician practice networks that serve them,” said John Potthoff, Ph.D., CEO of Elligo. “And Miranda brings a wealth of experience to the COO role as we continue to build out our team and hire the best minds in the industry. We look forward to continuing to expand our leadership team, technologies, and service offerings as we further our mission to ensure that all patients have access to clinical trials as a care option.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!